LSD1 promotes prostate cancer reprogramming by repressing TP53 signaling independently of its demethylase function.
JCI Insight
; 8(15)2023 08 08.
Article
in En
| MEDLINE
| ID: mdl-37440313
Full text:
1
Collection:
01-internacional
Database:
MEDLINE
Main subject:
Prostatic Neoplasms
/
Adenocarcinoma
Limits:
Humans
/
Male
Language:
En
Journal:
JCI Insight
Year:
2023
Document type:
Article